Abdullah et al.| Standardization of a unani pharmacopoeal compound formulation ‘Majoon-e-Piyaz’ INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY MEDICINE AND BIOALLIED SCIENCES An International, Multi-Disciplinary, Peer-Reviewed, Open Access, Indexed, Triannually Published Journal |www.biomedjournal.com| Standardization of a unani pharmacopoeal compound formulation „Majoon-ePiyaz‟ Abdullah1*, Saxena VK1, Manjeet Sinha1, Abdul Latif2 1Indian Medicines Pharmaceutical Corporation Ltd., A Government of India Enterprise, Mohan, Distt. Almora, Uttarakhand, India. of Ilmul Advia, Faculty of Unani Medicine, AMU, Aligarh, UP, India. 2Department SHORT COMMUNICATION ARTICLE INFORMATION Article history Received: 15 January 2015 Revised: 08 February 2015 Accepted: 15 February 2015 Early view: 20 March 2015 *Author for correspondence E-mail: [email protected] Q R C o d e ABSTRACT In Unani System of Medicine the drugs derived from natural sources are used, the majority of them are plant origin 85 %, animal origin 10% and mineral origin 5% but like any other system of medicine the efficacy of Unani System of Medicine also depends on potential and purity of the drugs used. To develop a mechanism for quality assurance of natural compound to ensure the purity of crude drugs material and its standardization is essential. Standardization and quality control are the key factors in regulating the therapeutic efficacy of Unani Herbal drugs. Organoleptic parameters are often insufficient in the quality assessment of Unani Herbal Drugs. The present study deal with compound Unani formulation of ‘Majoon Piyaz’ is compound formulation of NFUM Part I. It is a semi solid, dark brown colored compound formulation with sweet tending bitter in taste therapeutically used in Zof-e-Bah (Sexual debility), Jiryan (Spermatorrhoea) and Surat-e-Inzal (Premature ejaculation). Majoon-e-Piyaz is a natural product and is absolutely safe as it does not produce any side effects. In standardization of drug, the drug investigated through different chemical method, their active principals are being worked out, their percentage composition are as follow Total ash 1.38%, Acid-insoluble ash 0.58%, Water-soluble ash 0.52%, Alcohol Soluble Extractive 12.60%, Water Soluble Extractive 70.16%, pH values of 1% aqueous solution 4.77 o and 10% aqueous solution 4.58, Loss on drying at 105 C 17.06%. The Aflatoxin is estimated and reported that are not detected. In additin Heavy Metals, Microbial Load were done which are with in limit. This study will help in setting down Pharmacopoeial standards in determining the quality and purity of compound drug. Keywords: Majoon Piyaz, Standardization, quality control, Unani Formulation. Biomedjournal © Copyright 2013, All rights reserved. Biomedjournal Privacy Policy. INTRODUCTION The use of herbs and their formulations to treat diseases has stood the test of time. The chemical constituents present in them are a part of the physiological functions of living flora and hence they are believed to have better compatibility with the human body. That is why herbs and their products are now the centre of gravity for researches and application of it in treating the diseases. Plants and their products are composed of many constituents and are therefore, capable of variation. The variability of the plant material is due to different conditions of growth, harvesting, drying, and storage. The polarity of the solvent, the mode of extraction, and Int J Adv Pharmacy Med Bioallied Sci. 3, 1, 2015. the instability of constituents may also influence the composition and quality of the extracts. In olden times, Hakims used to treat patients on individual basis and prepare drug according to the requirements of the patient. Today herbal medicines however, are manufactured on a large scale in mechanical units, where manufacturers come across many problems such as non availability of good quality raw materials and proper methodology for standardization, etc., the availability of SOP (Standard Operational Procedure) for manufacturing units on large scale production is also lacking. (Afaq et al., 2012). The present study deal with compound Unani formulation of „Majoon Piyaz‟ is compound formulation of NFUM Part I. „Majoon Piyaz‟ is a semi solid, dark brown www.biomedjournal.com 42 Abdullah et al.| Standardization of a unani pharmacopoeal compound formulation ‘Majoon-e-Piyaz’ colored compound formulation with sweet tending bitter in taste therapeutically used in Zof-e-Bah (Sexual debility), Jiryan (Spermatorrhoea) and Surat-e-Inzal (Premature ejaculation) (Hakeem Mohammad Kabiruddin, 1978). MATERIALS AND METHODS Raw Materails The formulation contains the ingridients (Table 1& Figure 1) that are mentioned in part 1st of National Formulary of Unani Medicine (Anonymous, 2006). The raw materials were procured from the market through tender and their identity, purity and strength were checked as per reference, given in table 1. The commercial sample of Tudri Sufaid consists of dried seed of Cheiranthus cheiri Linn. (Family Brassiaceae) a shrub like herb cultivated in Indian gardens, frequently found in India and Iran. Tudri Sufaid was standardized and their standards are quoted here. Total Ash not more than 10%, Acid Insoluble Ash not more than 5.0%, Water Soluble not less than 6.0% and Alcohol Soluble extractive not less than 4.0%. Physicochemical Parameters Physicochemical studies like total ash; acid insoluble ash; water soluble ash; alcohol, petrolium Ether and water soluble matter; pH values of 1% aqueous solution; and 10% aqueous solution; loss on drying; were determined quantitatively according to methods recorded in Indian Pharmacopoeia (Anonymous, 1978(a), WHO guidelines (Anonymous, 1978(b), (Anonymous, 2005), and methods mentioned by Afaq et al, (1994). The determination of Atomic absorption for Heavy metals, presence of Aflotoxins and Microbial load were studied as per revised recomendation of WHO mentioned in its bulletin (Anonymous, 2005). Preparation of “Majoon-e-Piyaz” Ingredients of “Majoon-e-Piyaz) oral dosage form is mentioned in the Table-1. Clean, dry and powder the ingredients number 1 to 13 separately. Frequent cheking Table 1. Ingredients of „Majoon-e-Piayz‟. of particle size of powder was made. The powder of drug was passed through the sieve number 80. Ingredients number 15 dissolve the required quantity of sugar in 1000 ml of purified water and add Ingredients number 14 (Aab-e-Piyaz Sufaid) on slow heat, and at boiling stage add 0.5% alum, mix well and heat gently to prepare the qiwam of 75-76 % brix (two-three tar). Discontinue heating and while light hot add the fine powders of ingredient number 1 to 13, along with 0.6 % of sodium benzoate and mix thoroughly to get the homogenous product. Allow to cool to room temperature. Pack it in tightly closed containers to protect from light and moisture. Description: “Majoon-e-Piyaz” is a semi solid, dark brown colored compound formulation with sweet tending bitter in taste. Dose: 12 g. orally with milk/Arq-e-Gazar/fresh water once a day (H. M. Kabiruddin, 1978). RESULTS The “Majoon-e-Piyaz” investigated through different parameter of standardization and their percentage compositions are as follow: Total ash (1.38%), Acid insoluble ash (0.58%), Water soluble ash (0.52%), Alcohol soluble matter (12.60%), Water soluble matter (70.16%), Loss on drying at 105 oC (17.06%), pH 1% and 10% (4.77 & 4.58). These parameters are considered as tools of checking the quality, identity, purity and strength of the “Majoon-e-Piyaz” a semisolid compound formulation. The heavy metals, aflotoxins and Microbial load were also studied and reported (Table 3a, 3b, 3c, ) No growth of any Fingi or Bacteria were observed in the cultural media and no aflotoxines (B1,B2,G1,G2) were detected. Pb, Hg, and As are detected in the formulation but present with in the limit. No Aflotoxin, and Microb were detected hence passing all the test for its clinical use. S.N. Unani Name Botanical/ English Name Part Used Quantity Reference 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Tudri Surkh Tudri Safaid Salab Misri Behman Surkh Behman Safaid Zanjabeel Tukhm-e-Piyaz Tukhm-e-Turab Tukhm-e-Gandana Tukhm-e-Shalgham Talmakhana Musli Safaid Musli Siyah Aab-e-Piyaz Safed Qand Safaid Natroon Benzawi Shibb-e-Yamani Cheiranthus cheiri Linn Cheiranthus cheiri Linn Orchis latifolia Linn Salvia haematodes M Centaurea behen Linn. Zingiber officinale Allium cepa Raphanous sativus Asphodelus ternuifolius Brassica rapa Linn Euryale ferox Chlorphytum arundinaceum Curculigo orchioides Allium cepa Saccharum officinarum Sodium Benzoate Alum Seed Seed Tuber Root Root/Stem Root Rhizome Seed Seed Seed Seed Seed Root Root Fresh Bulb Crystal Crystal Crystal 3.5 g. 3.5 g. 3.5 g. 3.5 g. 3.5 g. 3.5 g. 3.5 g. 3.5 g. 3.5 g. 3.5 g. 3.5 g. 3.5 g. 3.5 g. 1.5 L. 1.5Kg. 0.6 % 0.5 % UPI-part-2, Vol.2,p.264 * UPI-part-1, Vol.3,p.88 UPI-part-1, Vol.3,p.23 UPI-part-1, Vol.3,p.21 UPI-part-1, Vol.1,p.88 UPI-part-1, Vol.3,p.19 UPI-part-1, Vol.5,p.101 UPI-part-1, Vol.6,p.88 UPI-part-1, Vol.3,p.99 UPI-part-1, Vol.3,p.107 UPI-part-1, Vol.2,p.79 API-part-1, Vol.4,p.122 UPI-part-1, Vol.3,p.17 API-part-1, Vol.6,p.218 IP, Vol.2, p. 684 UPI-part-2, Vol.2,p.229 Note: *1. Standardization of the raw material made in the laboratory and mentioned under the heading of material and method. Int J Adv Pharmacy Med Bioallied Sci. 3, 1, 2015. www.biomedjournal.com 43 Abdullah et al.| Standardization of a unani pharmacopoeal compound formulation ‘Majoon-e-Piyaz’ 2. UPI: The Unani Pharmacopoeia of India 3. API: The Ayourvedic Pharmacopoeia of India 4. IP: Indian Pharmacopoeia. Figure 1. Ingredients of “Majoon-e-Piyaz”. Tudri Surkh Tudri Sufaid Salab Misri Behman Surkh Behman Sufaid Zanjabeel Tukhm-e-Piyaz Tukhm-e-Turb Tukhm-e-Gandana Tukhm-e-Shalgham Talmakhana Musli Sufaid Musli Siyah Piyaz (Bulb) Qand Sufaid Table 3. Heavy Metals (a), Aflatoxin (b) and Microbial Load (c) of „Majoon-e-Piyaz‟. (a) Qualitative analysis for heavy metals. Shibb-e-Yamani Natroon, Benzawi S. No. Test Parameters Results* Limits 1 Lead as Pb Less than 10ppm 2 Mercury as Hg Less than 1ppm 3 Arsenic as As Less than 3ppm Not more than 10ppm Not more than 1ppm Not more than 3ppm Not more than 0.3ppm Less than Cadmium as 0.3ppm Cd *Each parameter is mean of three experiments. 4 Table 2. Physicochemical Properties of „Majoon-e-Piyaz‟. Parameter* Total ash Acid insoluble ash Water soluble ash Alcohol soluble matter Water soluble matter Loss on dry pH 1% pH 10% Majoon-e-Piyaz Not more than 1.38% Not more than 0.58% Not more than 0.52% Not less than 12.60% Not less than 70.16% Not more than 17.06% 4.77 4.58 Int J Adv Pharmacy Med Bioallied Sci. 3, 1, 2015. (b) Aflatoxin S. N. Aflatoxin Result* Limit 1 B1 Not detected Not more than 0.5ppm 2 B2 Not Detected Not more than 0.5ppm 3 G1 Not Detected Not more than 0.1ppm 4 G2 Not Detected Not more than 0.1ppm www.biomedjournal.com 44 Abdullah et al.| Standardization of a unani pharmacopoeal compound formulation ‘Majoon-e-Piyaz’ (c) Microbial Load S. N. Microbs Result* Limit 1 Total Bacterial Count Nil 2 Total Fungal Count Nil 3 E.coli Nil Nil 4 Salmonella Nil Nil 5 Staphylococcus aureus Nil Nil 6 P. aeruginosa Nil Nil Not more than 105 cfu/g Not more than 103 cfu/g Note. *All result based on three experiments DISCUSSION The present study is an attempt to ascertain the pharmacopoeial standards for the standardization of „Majoon-e-Piyaz‟. Majoon-e-Piyaz is a natural product and is absolutely safe as it does not produce any side effects. The parameters that are selected are those which are recommended by National Unani Pharmacopoea Committee. “Majoon-e-Piyaz” is a semi solid, dark brown colored compound formulation with sweet tending bitter in taste and during preperation of one batch 1-5% loss is expected. CONCLUSION The compound Unani Formulation „Majoon-e-Piyaz‟ used in the current study is of the standard parameter as given in Ayurevedic and Unani Pharmacopoeia. The above standards can be used for correct identification of market samples of drug. Anonymous. The Ayourvedic Pharmacopoeia of India; Part-I, Vol.VI; Gov.of India, Ministry of Health and Family welfare, AYUSH, N.Delhi; 2004. p.118, 122. Anonymous. Quality Control Methods for Medicinal Plant Material, WHO Revised DRAFT, UPDATE, September 2005. p. 4-5, 20-40. Anonymous. National Formulary of Unani Medicine Part I, Department of AYUSH, Ministry of Health and Family Welfare, Government of India; 2006. p. 139. Anonymous. The Unani Pharmacopoeia of India; Part-1, Vol.I; Gov.of India, Ministry of Health and Family welfare, AYUSH, N.Delhi; 2007. p.88. Anonymous . The Unani Pharmacopoeia of India; Part-1, Vol.II; Gov.of India, Ministry of Health and Family welfare, AYUSH, N.Delhi; 2007. p.79. Anonymous. The Unani Pharmacopoeia of India; Part-I, Vol.III; Gov.of India, Ministry of Health and Family welfare, AYUSH, N.Delhi; 2007. p.19, 21, 23, 88, 99, 107. Anonymous. The Unani Pharmacopoeia of India Part-I, Vol.V; Gov.of India, Ministry of Health and Family welfare, AYUSH, N.Delhi; 2008. p.101. Anonymous . The Unani Pharmacopoeia of India Part-I, Vol.VI; Gov.of India, Ministry of Health and Family welfare, AYUSH N.Delhi; 2009. p.88. Anonymous. The Unani Pharmacopoeia of India Part-II, Vol.II; Gov.of India, Ministry of Health and Family welfare, AYUSH, N.Delhi; 2010. p.229, 264. H. M. Kabiruddin. Biyaz-e-Kabir Vol.2nd, Shokat Book Depo, Shokat Bazar, Gujrat; 1978. p. 179. ACKNOWLEDGEMENT Authors are thankful to the Indian Medicines Pharmaceutical Corporation Ltd. A Government of India Enterprise Mohan, Distt. Almora, Uttarakhand (ViaRamnagar-244715), India for the financial & technical support. CONFLICT OF INTEREST None declared. REFERENCES Afaq SH, Tajuddin, Shamshad Ahmad, Abdullah & Azizur Rahman. Standardization of Unani Ointments „Marham Kafoor‟, Hippocratic Journal of Unani Medicine. 2012;12-25. Afaq SH, Tajuddin, Siddiqui MMH. Standardization of Herbal Drugs, Publication Division, AMU Aligarh. p. 44, 70, 145, 1994. Anonymous. Indian Pharmacopoeia, 4th Edn. Vol.2, Controller of publication, Govt. of India; 1978(a). p. 99, 442, 589. Anonymous. Quality control methods for medical plant materials World Health Organization, Geneva; 1978(b). p. 25-28. Anonymous. Indian Pharmacopoeia, Vol.2, Controller of publication, Govt. of India, p. 684, 1996. Int J Adv Pharmacy Med Bioallied Sci. 3, 1, 2015. www.biomedjournal.com 45
© Copyright 2024